Evolus Statistics
NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.52-0.48 (-6.86%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Evolus by the numbers
Evolus has a market capitalization of $431.5 million based on 66.19M shares outstanding. With trailing EPS of $-0.48, Evolus is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.4% below its 50-day average and 1.5% above its 200-day average.
Average daily trading volume is 925.77K shares, or about $6.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EOLS valuation vs. peer median
| Metric | EOLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $431.55M | $434.02M | -1% |
| Avg. volume | 925.77K | 1.14M | -19% |
Peer median across 8 companies: INDP, AQST, ARVN, PRTA, CAPR, LYEL, CTMX, CRMD.
Valuation
- Market cap
- $431.55M
- Forward P/E
- 22.68
- Price / sales (latest FY)
- 1.45
- EPS (TTM)
- $-0.48
- Shares outstanding
- 66.19M
Price and trading
- Previous close
- 7.00
- Open
- 6.79
- Day range
- 6.50 – 7.19
- 52-week range
- 3.86 – 9.31
- 52-week change
- -4.82%
- Beta
- —
- Volume
- 813.65K
- Average volume
- 925.77K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 431.55M
- Forward Pe
- 22.68
- Eps
- -0.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.31
- Week52 Low
- 3.86
- Avg Volume
- 925.77K
- Shares Outstanding
- 66.19M
- Ma50
- 7.45
- Ma200
- 6.42
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -29.97%
- Pct From52w Low
- 68.91%